Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 janv. 2024 04h08 HE | Source: Persistence Market Research

Antibiotic Resistance Market Projected to Hit US$ 17.8 Billion by 2033 with a CAGR of 5.3% | Persistence Market Research

New York, Jan. 12, 2024 (GLOBE NEWSWIRE) -- The growing demand for new antibiotic therapies to combat antibiotic resistance is a prominent driver in the global market. In a July 2023 Science Daily...
26 avr. 2017 15h28 HE | Source: Avivagen Inc.

Avivagen Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2017

OTTAWA, April 26, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...
12 avr. 2017 09h26 HE | Source: Avivagen Inc.

Avivagen Announces Results From Its Annual and Special Meeting of Shareholders

OTTAWA, April 12, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product...
10 avr. 2017 07h42 HE | Source: Avivagen Inc.

Avivagen Reports Positive Proof of Concept in Preventing C. Difficile Infection

OTTAWA, April 10, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...